Functionalization of Nanosystems in Cancer Treatment
Main Author: | |
---|---|
Publication Date: | 2022 |
Other Authors: | , , , , |
Format: | Book part |
Language: | eng |
Source: | Repositório Institucional da UNESP |
Download full: | http://dx.doi.org/10.1007/978-3-031-17831-3_3 http://hdl.handle.net/11449/250008 |
Summary: | Cancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization. |
id |
UNSP_eab7b4ac842f664ca8d220660a7cc835 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/250008 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Functionalization of Nanosystems in Cancer TreatmentActive targetingCarbodiimide chemistryClick chemistryMaleimide chemistryTargeting ligandsCancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization.School of Pharmaceutical Sciences of Ribeirao Preto University of Sao PauloSchool of pharmaceutical Sciences Sao Paulo State UniversitySchool of pharmaceutical Sciences Sao Paulo State UniversityUniversidade de São Paulo (USP)Universidade Estadual Paulista (UNESP)Luiz, Marcela TavaresDutra, Jessyca Aparecida Paes [UNESP]De Araújo, Jennifer Thayanne Cavalcante [UNESP]Di Filippo, Leonardo Delello [UNESP]Duarte, Jonatas Lobato [UNESP]Chorilli, Marlus [UNESP]2023-07-29T16:15:13Z2023-07-29T16:15:13Z2022-01-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bookPart71-101http://dx.doi.org/10.1007/978-3-031-17831-3_3Cancer Nanotechnology, p. 71-101.http://hdl.handle.net/11449/25000810.1007/978-3-031-17831-3_32-s2.0-85160483626Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengCancer Nanotechnologyinfo:eu-repo/semantics/openAccess2025-03-29T05:19:45Zoai:repositorio.unesp.br:11449/250008Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-03-29T05:19:45Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Functionalization of Nanosystems in Cancer Treatment |
title |
Functionalization of Nanosystems in Cancer Treatment |
spellingShingle |
Functionalization of Nanosystems in Cancer Treatment Luiz, Marcela Tavares Active targeting Carbodiimide chemistry Click chemistry Maleimide chemistry Targeting ligands |
title_short |
Functionalization of Nanosystems in Cancer Treatment |
title_full |
Functionalization of Nanosystems in Cancer Treatment |
title_fullStr |
Functionalization of Nanosystems in Cancer Treatment |
title_full_unstemmed |
Functionalization of Nanosystems in Cancer Treatment |
title_sort |
Functionalization of Nanosystems in Cancer Treatment |
author |
Luiz, Marcela Tavares |
author_facet |
Luiz, Marcela Tavares Dutra, Jessyca Aparecida Paes [UNESP] De Araújo, Jennifer Thayanne Cavalcante [UNESP] Di Filippo, Leonardo Delello [UNESP] Duarte, Jonatas Lobato [UNESP] Chorilli, Marlus [UNESP] |
author_role |
author |
author2 |
Dutra, Jessyca Aparecida Paes [UNESP] De Araújo, Jennifer Thayanne Cavalcante [UNESP] Di Filippo, Leonardo Delello [UNESP] Duarte, Jonatas Lobato [UNESP] Chorilli, Marlus [UNESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Estadual Paulista (UNESP) |
dc.contributor.author.fl_str_mv |
Luiz, Marcela Tavares Dutra, Jessyca Aparecida Paes [UNESP] De Araújo, Jennifer Thayanne Cavalcante [UNESP] Di Filippo, Leonardo Delello [UNESP] Duarte, Jonatas Lobato [UNESP] Chorilli, Marlus [UNESP] |
dc.subject.por.fl_str_mv |
Active targeting Carbodiimide chemistry Click chemistry Maleimide chemistry Targeting ligands |
topic |
Active targeting Carbodiimide chemistry Click chemistry Maleimide chemistry Targeting ligands |
description |
Cancer is the major public health problem worldwide, with high rates of incidence and lethality. The leak of specificity of the treatments currently available results in several side effects and reduced efficacy. Thus, nanosystems have demonstrated great potential for the delivery of chemotherapeutic agents to tumors due to their ability to passively accumulate in the tumor through enhanced permeability and retention (EPR) effect, to carry of hydrophilic and hydrophobic drugs, and to protect the drugs against degradation. In recent decades, advances in nanosystems design have expanded their therapeutic potential due to the inclusion of targeting ligands that can be specifically recognized by receptors overexpressed on tumor cells. Among these targeting ligands, antibodies, antibodies’ fragments, peptides, and small molecules have been widely incorporated in nanosystems for promoting the active targeting to the tumors. The modification of nanosystems with these ligands can be performed before or after nanosystems’ production through non-covalent or covalent functionalization, which can result in different biological activities. In this context, the present chapter aims to present some aspects of the synthesis employed to functionalize nanosystems. In addition, we address the main targeting ligands used for promoting the active targeting of nanosystems to different cancer cells, discussing the in vitro and in vivo results obtained for each functionalization. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 2023-07-29T16:15:13Z 2023-07-29T16:15:13Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bookPart |
format |
bookPart |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1007/978-3-031-17831-3_3 Cancer Nanotechnology, p. 71-101. http://hdl.handle.net/11449/250008 10.1007/978-3-031-17831-3_3 2-s2.0-85160483626 |
url |
http://dx.doi.org/10.1007/978-3-031-17831-3_3 http://hdl.handle.net/11449/250008 |
identifier_str_mv |
Cancer Nanotechnology, p. 71-101. 10.1007/978-3-031-17831-3_3 2-s2.0-85160483626 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Cancer Nanotechnology |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
71-101 |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1834482558612537344 |